CY1117371T1 - USE OF CYCLEZONIDE FOR RESPIRATORY DISEASE TREATMENT - Google Patents

USE OF CYCLEZONIDE FOR RESPIRATORY DISEASE TREATMENT

Info

Publication number
CY1117371T1
CY1117371T1 CY20141100162T CY141100162T CY1117371T1 CY 1117371 T1 CY1117371 T1 CY 1117371T1 CY 20141100162 T CY20141100162 T CY 20141100162T CY 141100162 T CY141100162 T CY 141100162T CY 1117371 T1 CY1117371 T1 CY 1117371T1
Authority
CY
Cyprus
Prior art keywords
cyclezonide
respiratory disease
disease treatment
treatment
relates
Prior art date
Application number
CY20141100162T
Other languages
Greek (el)
Inventor
Thomas Bethke
Renate Engelstaetter
Wilhelm Wurst
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04766791.0A external-priority patent/EP1670482B2/en
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of CY1117371T1 publication Critical patent/CY1117371T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Αυτή η εφεύρεση αναφέρεται σε μια νέα μέθοδο θεραπείας αναπνευστικών νοσημάτων, συγκεκριμένα στη θεραπεία ασθματικών παιδιών.This invention relates to a new method of treating respiratory diseases, in particular the treatment of asthmatic children.

CY20141100162T 2003-09-16 2014-02-27 USE OF CYCLEZONIDE FOR RESPIRATORY DISEASE TREATMENT CY1117371T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50298403A 2003-09-16 2003-09-16
EP04766791.0A EP1670482B2 (en) 2003-09-16 2004-09-15 Use of ciclesonide for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
CY1117371T1 true CY1117371T1 (en) 2017-04-26

Family

ID=58606611

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100162T CY1117371T1 (en) 2003-09-16 2014-02-27 USE OF CYCLEZONIDE FOR RESPIRATORY DISEASE TREATMENT

Country Status (2)

Country Link
CY (1) CY1117371T1 (en)
SI (1) SI1670482T2 (en)

Also Published As

Publication number Publication date
SI1670482T2 (en) 2022-10-28
SI1670482T1 (en) 2014-04-30

Similar Documents

Publication Publication Date Title
CY1120022T1 (en) Pediatric Acute Acute Lymphoblastic Leukemia Treatment
ATE390407T1 (en) PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
DE602004020072D1 (en) 1,2,3,4-TETRASUBSTITUTED INDOL FOR THE TREATMENT OF RESPIRATORY DISEASES
IS2994B (en) Phosphonates, monophosphonamides, bisphosphonamides for the treatment of viral diseases
CY1118472T1 (en) Substituted acylanilides and methods of their use
CY1112067T1 (en) USE OF FLIBANSERINE FOR THE TREATMENT OF PRE-MONOPOLY DISORDERS
CY1107084T1 (en) PYRROLOPYRIDAZINE PRODUCERS
ATE447551T1 (en) BIPHENYLOXYACETIC ACID - DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
CY1106386T1 (en) SUBSTITUTED 3-PYRROLIDINE-INDOLE DERIVATIVES
ATE476414T1 (en) BIPHENYLOXYACETIC ACID DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
CY1106774T1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON SALTS OF TIOTROPIUM AND SALTS OF SALMETEROL
CY1113190T1 (en) METHOD OF TREATMENT OF HEMOLYTIC DISEASE
EA200802213A1 (en) METHODS OF TREATING BLOOD DISEASES
BRPI0307673A2 (en) methods of treating vascular disease.
EA200901211A1 (en) ANTIGENS OF C5 PROTEIN AND THEIR APPLICATION
EA200700851A1 (en) OBTAINING AND APPLICATION OF BIPHENYL-4-ILKARBONYLAMINO ACID DERIVATIVES FOR TREATMENT OF OBESITY
ATE517085T1 (en) PHENOXYACETIC ACID DERIVATIVES SUITABLE FOR THE TREATMENT OF RESPIRATORY DISEASES
NO20074999L (en) Method and preparation for the treatment of peripheral vascular diseases
DE602005017636D1 (en) NEW HYDANTINE DERIVATIVES FOR THE TREATMENT OF OBSTRUCTIVE RESPIRATORY DISEASES
CY1124281T1 (en) THERAPEUTIC USE OF A SPECIFIC ADAPTER IN MSRV-RELATED DISEASES
NO20050063L (en) 2-heteroaryl carboxamides
ATE496913T1 (en) NEW, LONG-ACTING BETAMIMETICS FOR THE TREATMENT OF RESPIRATORY DISEASES
EA200700637A1 (en) SALTED NIPPLE, SUITABLE FOR OBTAINING PHARMACEUTICAL COMPOSITIONS
ATE448232T1 (en) SUBSTITUTED HETEROCYCLES
CY1111799T1 (en) NEW METHODS